US20030082133A1 - Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials - Google Patents

Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials Download PDF

Info

Publication number
US20030082133A1
US20030082133A1 US10/309,628 US30962802A US2003082133A1 US 20030082133 A1 US20030082133 A1 US 20030082133A1 US 30962802 A US30962802 A US 30962802A US 2003082133 A1 US2003082133 A1 US 2003082133A1
Authority
US
United States
Prior art keywords
dendrimer
biocide
silver
dendrimer biocide
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/309,628
Inventor
Stuart Cooper
Chris Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Delaware
Original Assignee
Cooper Stuart L.
Chen Chris Z.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooper Stuart L., Chen Chris Z. filed Critical Cooper Stuart L.
Priority to US10/309,628 priority Critical patent/US20030082133A1/en
Publication of US20030082133A1 publication Critical patent/US20030082133A1/en
Assigned to UD TECHNOLOGY CORPORATION reassignment UD TECHNOLOGY CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THE UNIVERSITY OF DELAWARE OFFICE OF THE VICE PROVOST FOR RESEARCH
Assigned to UNIVERSITY OF DELAWARE reassignment UNIVERSITY OF DELAWARE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: UD TECHNOLOGY CORPORATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002Dendritic macromolecules
    • C08G83/003Dendrimers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to the synthesis and characterization of a series of new compositions of matter, formulations, and applications of dendrimer biocide-silver nanocomposites as potent antimicrobial agents.
  • Dendrimers are well defined, highly branched macromolecules that emanate from a central core.
  • Commercially available dendrimers include polyamidoamine (“PAMAM”) dendrimers and polypropylene imine (“PPI”) dendrimers.
  • PAMAM polyamidoamine
  • PPI polypropylene imine
  • Dendriditic architecture brings a very high number of functional groups in a compact space.
  • Dendrimers in the present invention can for example be selected from the group consisting of polyamidoamine dendrimers, polylysine based dendrimers, polyethylene oxide based dendrimers, silicon based dendrimers, polyether based dendrimer and polypropylene imine dendrimers.
  • a polylysine based dendrimers refers to a dendrimer in which the backbone or structure consists essentially of polylysine.
  • a polyethylene oxide based dendrimers refers to a dendrimer in which the backbone or structure consists essentially of polyethylene oxide.
  • a silicon based dendrimers refers to a dendrimer in which the backbone or structure consists essentially of silicon.
  • a polyether based dendrimer refers to a dendrimer in which the backbone or structure consists essentially of polyether.
  • Dendrimers can be tailored to generate uniform or discrete functionalities and possess tunable inner cavities, surface moieties, sizes, molecular weights, and solvent interactions. Dendrimers can be synthesized by a convergent approach, see Tomalia, et al., Macromolecules, 20 at 1164 (1987), alternatively, dendrimers can also be synthesized by a divergent approach, see Tang, et al., Bioconjugate Chem., 7 at 703-714 (1996).
  • dendrimers In the divergent approach, growth of dendrimers starts from a multi-functional core. Through a series of reaction and purification steps, dendrimers grow radially outwards. At different stages of the synthesis, dendrimers are identified by generations. As the generation increases, the number of functional groups, the size of the dendrimer, and the molecular weight of the dendrimer increase.
  • Commercially available dendrimers such as polyamidoamine (PAMAM) dendrimers from Dendritech Inc. (Midland, Mich., USA) and polypropylene imine (PPI) dendrimers from DSM (Geleen, Netherlands) are synthesized by the divergent approach.
  • PAMAM polyamidoamine
  • PPI polypropylene imine
  • dendrons as parts of dendrimers, are synthesized according to the divergent approach and these dendrons are then coupled to a multifunctional core.
  • the advantage of the convergent approach is that the chemistry of each dendron can be different, and distinct functional groups can be integrated into dendrimers at precise sites. Due to the repetitive nature of the dendrimer synthesis and the extensive purification required, dendrimers are very expensive and not readily available. The combination of discrete numbers of functionalities in one molecule and high local densities of active groups has attracted a lot of attention, especially for biological applications.
  • dendriditic architecture of dendrimers provides a very high number of functional groups in a compact space. Because of this property, it is reasonable to expect that these novel molecules will play a major role in materials whose performance depends on high local concentration, such as drugs or antimicrobial agents.
  • the versatile chemistry of the dendrimers can also include metal atoms.
  • the metal can be either an integral part of the dendrimer, such as in the building block, core, or terminal group, or it can associate with the dendrimer through interactions with branching units. These metals can be metal cations, metal salts, metal oxides or even elemental metal. Newkome and coworkers published a recent comprehensive review on dendrimers with metals (metallodendrimers) G. R. Newkome, E. He, C. N. Moorefield, Chem. Rev. 1999, 99, 1689. Metal salts, such as silver, are known antimicrobial agents. Dendrimer nanocomposites, formed by dendrimers and antimicrobial salts, offer a new way to deliver or enhance the antimicrobial properties of these agents.
  • the inventors have successfully synthesized novel dendrimer biocides. These dendrimer biocides are fully described in U.S. patent application Ser. No. 09/588,585, which is herein incorporated by reference for all purposes.
  • the present invention is directed to novel dendrimer biocide-silver complexes, which are new nanocomposites synthesized from the dendrimer biocides of the U.S. patent application Ser. No. 09/588,585 and silver salts.
  • the hybrid structures embodying the present invention provide even more potent antimicrobial properties.
  • the described dendrimer biocides are capable of killing anthrax spores.
  • the inventors have unexpectedly found that the dendrimer biocide-silver nanocomposites have superior biocide properties.
  • the synergy between the dendrimer biocide and the silver ion has great potential for denaturing spores. Because spores are a significant class of biological weapons, the present invention would be useful in combating biological warfare weapons.
  • the invention can also be used in any situation that requires a potent biocide that is also environmentally stable. These applications include incorporation into protective coatings or paints, personal products such as cosmetics, industrial products, hospital products, and sanitation of swimming pools and spas.
  • the invention can also be immobilized onto the surface to create efficient antimicrobial surfaces for use as biomaterials, antifouling paints, and other similar devices.
  • the object of the invention is to provide a dendrimer biocide-silver complex, and the method of using the dendrimer biocide-silver complex as an antimicrobial agent.
  • silver nitrate (AgNO 3 ) is added to a dendrimer biocide solution to obtain a novel dendrimer-silver complex containing both dendrimer and silver ions.
  • FIG. 1 Plot showing the antibacterial activity of dendrimer-silver nanocomposites compared to dendrimer biocide alone.
  • the novel dendrimer biocide-silver composite compositions of the present invention are prepared by reacting a dendrimer biocide with silver compound.
  • the dendrimer biocides of the present invention are fully described in U.S. patent application Ser. No. 09/588,585, which is herein incorporated by reference.
  • the dendrimer biocides of the present invention are the quatemary ammonium functionalized dendrimers of Formula I:
  • D is a dendrimer
  • n is the generation number of the functionalized dendrimer
  • z is an integer less than or equal to 2(n+1)
  • X ⁇ is an anion
  • R is a linking group
  • Y is an alkyl group or aryl group
  • A is an alkyl group or aryl group
  • B is an alkyl group or aryl group.
  • D is a poly(propylene imine) (“PPI”) dendrimer of generation n and having an anion X and a Y group.
  • PPI poly(propylene imine)
  • D3ClNC8 denotes a dimethyloctyl (C 8 ) ammonium (N) chloride (Cl) functionalized PPI generation 3 dendrimer (D3).
  • the dendrimer biocide-silver nanocomposites are prepared by a process comprising the following steps:
  • greater than 1 percent stoichiometric amount of a silver compound may be used to prepare the dendrimer biocide-silver nanocomposite.
  • the inventors further discovered that the dendrimer biocide-silver nanocomposite structures are only stable in water. If the water was evaporated under vacuum, redissolution was impossible and a dark powder of Ag 2 O was observed with powdered dendrimer biocide residue.
  • the inventors believe that the novel dendrimer biocide-silver nanocomposite compounds contain both dendrimer and silver ions. While not wishing to be bound to a particular theory, the inventors believe that the silver ions may be absorbed on or complexed with the dendrimer. Depending on the composition of the solution, these nanocomposites can be stable for more than 3 months compared to several-hour stability of other dendrimer-nanocomposite preparations.
  • Dendrimer biocide-silver nanocomposites were prepared by initially reacting silver nitrate (AgNO 3 ) with a D3ClNC8 dendrimer biocide to prepare a dendrimer biocide with nitrate counter-anion.
  • the dendrimer biocide with nitrate counter-anion was prepared according to the method described above as follows:
  • the sample Ag-200 refers to the sample when a 200 percent stoichiometric amount of AgNO 3 was used in preparing the dendrimer biocide-silver nanocomposite.
  • Approximately 0.1 gram of D3ClNC16 is dissolved in minimal amount of ethanol and dilute with water to obtain 10 mL solution.
  • 10 mL of 0.1N AgNO3 is then added to change the counter anion of the dendrimer to nitrate.
  • the solution is then centrifuged at 3000 g for 2 hours.
  • the supematant is collected and 10 mL of 0.1N NaCl is added to remove the residual amount of AgNO3 in the solution.
  • the excess NaCl was then removed with diafiltration of distilled water (1000 MWCO membrane).
  • the final volume after diafiltration can be adjusted according to the desired concentration. Typically a 100 mL solution is achieved.
  • the sample Ag-500 refers to the sample when a 500 percent stoichiometric amount of AgNO 3 was used in preparing the dendrimer biocide-silver nanocomposite.
  • Approximately 0.1 gram of D3ClNC16 is dissolved in minimal amount of ethanol and dilute with water to obtain 10 mL solution.
  • 25 mL of 0.1N AgNO3 is then added to change the counter anion of the dendrimer to nitrate.
  • the solution is then centrifuged at 3000 g for 2 hours. The supernatant is collected and 25 mL of 0.1N NaCl is added to remove the residual amount of AgNO3 in the solution.
  • the excess NaCl was then removed with diafiltration of distilled water (1000 MWCO membrane).
  • the final volume after diafiltration can be adjusted according to the desired concentration.
  • E. coli stock solutions kept at ⁇ 80° C. freezer until required for use, were prepared in Lucia-Barton (LB) media supplemented with 20% glycerol. Glycerol was added to protect bacteria during freezing and thawing processes.
  • LB Lucia-Barton
  • Glycerol was added to protect bacteria during freezing and thawing processes.
  • a required amount of E. coli suspension (typically 10%) was added to fresh and sterile LB broth and incubated overnight at 37° C. These cells were also centrifuged and washed twice with phosphate buffered saline. Cell concentration was determined using a Petroff-Hausser counting chamber (Scientific Products, Edison, N.J.). Bacteria suspensions were then diluted to the test concentration. The recombinant E.
  • coli strains were also stocked in a similar way to the wild-type E. coli .
  • the medium used was Lucia-Barton (LB) supplemented with 25 mg/ml kanamycin monosulfate to maintain the plasmid.
  • LB Lucia-Barton
  • These plasmid-containing strains were grown to an early exponential phase at 30° C. The temperature used was lower than normal because enzymes responsible for generating light would be deactivated at 37° C.
  • These cells were also centrifuged and washed twice with 0.1% peptone water before use.
  • Antimicrobial test results might be reported qualitatively, using terms as sensitive, intermediate, or resistant, or quantitatively in terms of concentration of an agent needed to inhibit or kill bacteria.
  • Suspension tests are typically used to evaluate water-soluble antimicrobials, while surface antimicrobial tests are designed to characterize the antimicrobial properties of non-leaching biocidal materials.
  • E. coli For the bioluminescence experiments, several strains of recombinant E. coli were used. These recombinant E. coli strains containing a fusion of Escherichia coli heat shock promoters. Whenever bacteria receive stress from a toxic compound, the intensity of light emitted from the bacteria will change. From a “light-on” or “light-off” response one can obtain real-time cell viability data. Strain TV 1048, in which the lux operon is coupled to the promoter of lac operon, was used in this study. Bioluminescence is observed under normal growth conditions. Whenever the bacteria are in a biocidal environment, the light-off response quantitatively corresponds to the antibacterial effect.
  • the antibacterial property of the D3ClNC8 dendrimer biocide-silver nanocomposite against Gram-negative E. coli was determined by a bioluminescence method. Bioluminescence is observed under normal growth conditions for the recombinant E. coli strain TV 1048. Whenever the bacteria are in a biocidal environment, the light-off response corresponds to the toxic effect of the biocide. The result is expressed as the sample bioluminescence normalized to a control (without biocidal dendrimer of the present invention) versus time. The reduction of luminescence quantitatively shows the antibacterial activity of the sample.
  • the sample Ag-200 refers to the sample when a 200 percent stoichiometric amount of AgNO 3 was used in preparing the dendrimer biocide-silver nanocomposite.
  • the Ag-200 formulation was observed to be much more potent than the dendrimer biocide alone. See FIG. 1. This figure shows that 2 ppm of D3ClNC8 reduces the bioluminescence to only 10 percent of the bioluminescence of the control.
  • formulation Ag-500, containing only 0.8 ppm of D3ClNC8 and less than 0.8 ppm of Ag + can reduce the bioluminescence to 0.1 percent of the control. The exact silver concentration was unknown since some AgCl precipitate consumed Ag + ).
  • the more potent formulation, Ag-200 with 0.8 ppm of D3ClNC8 and less than 0.3 ppm of Ag + can reduce the bioluminescence to 0.001 percent of the control, which corresponded to a 5-order of magnitude reduction.
  • the inventors further observed that the Ag-200 formulation is unexpectedly more potent than Ag-500 formulation.
  • the improvement of the potency may be explained by synergy between the dendrimer biocide and silver ions.
  • Silver ions have been used as antimicrobials for 4000 years. The mode of action of silver ion is similar to Hg 2+ . Both ions can complex with electron donor groups containing sulfur, oxygen or nitrogen. Silver parallels mercuric ions in relative affinities for various proteins, but is somewhat less tightly bound.
  • Synergism is defined as the ability of two antimicrobials acting together to markedly increase the rate of the bacteriocidal action as compared to the rate of each antimicrobial alone.
  • a typical example of synergy is between EDTA and QACs. EDTA is able to chelate the calcium and magnesium, thus destabilizes the phospholipid membrane and promotes the membrane-disrupting action of QACs.

Abstract

A novel cationic dendrimer biocide-silver nanocomposite and methods for its use as a biocide. The biocidal nanocomposites of the present invention are effective against a variety of microbial species, including anthrax. The invention is also highly stable and safe for exposure to human skin. The invention has applications as an antibiological warfare agents, antimicrobial agent for surface coatings and as a general biocide that is safe for human exposure.

Description

    CLAIM OF PRIORITY
  • Priority is claimed under 35 U.S.C. §119(e) from the U.S. Provisional Application Serial No. 60/210,888 filed Jun. 9, 2000; which is herein incorporated by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • The present invention relates to the synthesis and characterization of a series of new compositions of matter, formulations, and applications of dendrimer biocide-silver nanocomposites as potent antimicrobial agents. [0003]
  • 2. Description of the Related Art [0004]
  • Dendrimers are well defined, highly branched macromolecules that emanate from a central core. Commercially available dendrimers include polyamidoamine (“PAMAM”) dendrimers and polypropylene imine (“PPI”) dendrimers. Dendriditic architecture brings a very high number of functional groups in a compact space. Dendrimers in the present invention can for example be selected from the group consisting of polyamidoamine dendrimers, polylysine based dendrimers, polyethylene oxide based dendrimers, silicon based dendrimers, polyether based dendrimer and polypropylene imine dendrimers. A polylysine based dendrimers refers to a dendrimer in which the backbone or structure consists essentially of polylysine. A polyethylene oxide based dendrimers refers to a dendrimer in which the backbone or structure consists essentially of polyethylene oxide. A silicon based dendrimers refers to a dendrimer in which the backbone or structure consists essentially of silicon. A polyether based dendrimer refers to a dendrimer in which the backbone or structure consists essentially of polyether. [0005]
  • The advent of dendrimers represents a major breakthrough in synthetic chemistry. Dendrimers can be tailored to generate uniform or discrete functionalities and possess tunable inner cavities, surface moieties, sizes, molecular weights, and solvent interactions. Dendrimers can be synthesized by a convergent approach, see Tomalia, et al., [0006] Macromolecules, 20 at 1164 (1987), alternatively, dendrimers can also be synthesized by a divergent approach, see Tang, et al., Bioconjugate Chem., 7 at 703-714 (1996).
  • In the divergent approach, growth of dendrimers starts from a multi-functional core. Through a series of reaction and purification steps, dendrimers grow radially outwards. At different stages of the synthesis, dendrimers are identified by generations. As the generation increases, the number of functional groups, the size of the dendrimer, and the molecular weight of the dendrimer increase. Commercially available dendrimers, such as polyamidoamine (PAMAM) dendrimers from Dendritech Inc. (Midland, Mich., USA) and polypropylene imine (PPI) dendrimers from DSM (Geleen, Netherlands) are synthesized by the divergent approach. [0007]
  • In the convergent approach, dendrons, as parts of dendrimers, are synthesized according to the divergent approach and these dendrons are then coupled to a multifunctional core. The advantage of the convergent approach is that the chemistry of each dendron can be different, and distinct functional groups can be integrated into dendrimers at precise sites. Due to the repetitive nature of the dendrimer synthesis and the extensive purification required, dendrimers are very expensive and not readily available. The combination of discrete numbers of functionalities in one molecule and high local densities of active groups has attracted a lot of attention, especially for biological applications. The unique architecture of dendrimers, they have been investigated for a wide variety of applications, such as gene delivery vesicles, Tang, et al., [0008] Bioconjugate Chem., 7 at 703-714 (1996); Kukowska-Latallo, et al., Proc. Natl. Acad. Sci USA, 93 at 4897-4902 (1996), catalysts, Zeng, F. Z., S. C. Chem. Rev., 97 at 1681 (1997); Newkome, et al., Chem. Rev., 99 at 1689-1746 (1999), drug delivery carriers, Liu, M.; Frechet, J. M., J. Proc. Am. Chem. Soc. Polym. Mater. Sci. Engr., 80 at 167 (1999); Uhrich, K., TRIP, 5 at 388-393 (1997); Liu, H.; Uhrich, K. Proc, Am. Chem. Soc. Div. Polym. Chem., 38 at 1226 (1997), chromatography stationary phases, Matthews, et al., Prog. Polym. Sci., 23 at 1-56 (1998), boron neutron capture therapy agents, Newkome, et al., Dendritic Macromolecules: Concepts, Syntheses, Perspectives; VCH: Weinheim, Germany (1996); Newkome, G. R., Advances in Den dritic Macromolecules; JAI Press: Greenwich, Conn., Vol. 2 (1995), and magnetic resonance imaging contrast agents. Tomalia, D. A. Adv. Mater., 6 at 529-539 (1994).
  • The dendriditic architecture of dendrimers provides a very high number of functional groups in a compact space. Because of this property, it is reasonable to expect that these novel molecules will play a major role in materials whose performance depends on high local concentration, such as drugs or antimicrobial agents. [0009]
  • The versatile chemistry of the dendrimers can also include metal atoms. The metal can be either an integral part of the dendrimer, such as in the building block, core, or terminal group, or it can associate with the dendrimer through interactions with branching units. These metals can be metal cations, metal salts, metal oxides or even elemental metal. Newkome and coworkers published a recent comprehensive review on dendrimers with metals (metallodendrimers) G. R. Newkome, E. He, C. N. Moorefield, [0010] Chem. Rev. 1999, 99, 1689. Metal salts, such as silver, are known antimicrobial agents. Dendrimer nanocomposites, formed by dendrimers and antimicrobial salts, offer a new way to deliver or enhance the antimicrobial properties of these agents.
  • Balogh et al. synthesized dendrimer nanocomposites, dendrimers with inorganic silver or silver ions, and tested their antibacterial properties. Balogh, L. [0011] Proc. Am. Chem. Soc. Div. Colloi & Surf. Chem., 54. (1999). For these dendrimer nanocomposites, the dendrimer itself does not have any antibacterial property. The activity comes from the silver/silver ions. In contrast, the quaternary ammonium functionalized dendrimers of the current invention derive antibacterial properties from the dendrimer itself. The dendrimers of the current invention are different from all previous investigations in that the surface groups of the dendrimers were transformed into quaternary ammonium groups. Unlike known QACs, the quaternary ammonium functionalized dendrimers of the current invention are more effective against Gram-negative bacteria such as E. coli and Gram-positive bacteria such as S.aures.
  • SUMMARY OF THE INVENTION
  • The inventors have successfully synthesized novel dendrimer biocides. These dendrimer biocides are fully described in U.S. patent application Ser. No. 09/588,585, which is herein incorporated by reference for all purposes. The present invention is directed to novel dendrimer biocide-silver complexes, which are new nanocomposites synthesized from the dendrimer biocides of the U.S. patent application Ser. No. 09/588,585 and silver salts. The hybrid structures embodying the present invention provide even more potent antimicrobial properties. [0012]
  • The structure investigated in this study is not very clear. A tentative name of “dendrimer silver nanocomposite” was used. The potent biocide properties of the dendrimer-silver nanocomposites according to the invention all came by surprise to the inventors. [0013]
  • In the copending patent application Ser. No. 09/588,585, the described dendrimer biocides are capable of killing anthrax spores. However, the inventors have unexpectedly found that the dendrimer biocide-silver nanocomposites have superior biocide properties. The synergy between the dendrimer biocide and the silver ion has great potential for denaturing spores. Because spores are a significant class of biological weapons, the present invention would be useful in combating biological warfare weapons. [0014]
  • Traditional antibiological warfare agents are known to be very reactive and extremely toxic. Such agents include chlorine, formaldehyde, and peroxygen. In contrast, the novel dendrimer biocide-silver nanocomposites of the present invention are nonreactive and are virtually nontoxic to human skin. Similar compounds have been used in hand-wash formulations. Thus, the invention may provide an effective antibiological warfare agent. Examples of uses for the present invention include a denaturing spray or soldier uniforms impregnated with the invention. [0015]
  • Additionally, the invention can also be used in any situation that requires a potent biocide that is also environmentally stable. These applications include incorporation into protective coatings or paints, personal products such as cosmetics, industrial products, hospital products, and sanitation of swimming pools and spas. The invention can also be immobilized onto the surface to create efficient antimicrobial surfaces for use as biomaterials, antifouling paints, and other similar devices. [0016]
  • The object of the invention is to provide a dendrimer biocide-silver complex, and the method of using the dendrimer biocide-silver complex as an antimicrobial agent. [0017]
  • In accordance with the invention, silver nitrate (AgNO[0018] 3) is added to a dendrimer biocide solution to obtain a novel dendrimer-silver complex containing both dendrimer and silver ions.
  • DESCRIPTION OF FIGURES
  • FIG. 1. Plot showing the antibacterial activity of dendrimer-silver nanocomposites compared to dendrimer biocide alone.[0019]
  • DETAILED DESCRIPTION OF THE INVENTION
  • The novel dendrimer biocide-silver composite compositions of the present invention are prepared by reacting a dendrimer biocide with silver compound. The dendrimer biocides of the present invention are fully described in U.S. patent application Ser. No. 09/588,585, which is herein incorporated by reference. The dendrimer biocides of the present invention are the quatemary ammonium functionalized dendrimers of Formula I: [0020]
    Figure US20030082133A1-20030501-C00001
  • where D is a dendrimer; n is the generation number of the functionalized dendrimer; z is an integer less than or equal to 2(n+1); X[0021] is an anion; R is a linking group; Y is an alkyl group or aryl group; A is an alkyl group or aryl group, and B is an alkyl group or aryl group. The quaternary ammonium functionalized dendrimers are then reacted with silver compound to form the dendrimer biocide-silver nanocomposites of the present invention.
  • To simplify the naming of the dendrimer biocides used in the present invention, a shorthand of “DnXNY” based on [0022] Formula 1 is used. In this shorthand format, D is a poly(propylene imine) (“PPI”) dendrimer of generation n and having an anion X and a Y group. For example, “D3ClNC8” denotes a dimethyloctyl (C8) ammonium (N) chloride (Cl) functionalized PPI generation 3 dendrimer (D3).
  • The dendrimer biocide-silver nanocomposites are prepared by a process comprising the following steps: [0023]
  • (1) adding excess AgNO[0024] 3 to the dendrimer biocide solution to convert the chloride ion of the dendrimer biocide to a nitrate ion;
  • (2) removing any precipitated AgCl; [0025]
  • (3) removing any remaining AgNO[0026] 3 in the solution by adding excess NaCl to the supernatant liquid; and
  • (4) diafilter to remove remaining NaCl. [0027]
  • In a preferred embodiment greater than 1 percent stoichiometric amount of a silver compound may be used to prepare the dendrimer biocide-silver nanocomposite. [0028]
  • In the above process, the inventors unexpectedly found that there was still some silver ions left in the solution even when excess NaCl was added in step 3. These silver ions seemed to prefer to stay associated with the dendrimer rather than forming AgCl precipitate. [0029]
  • The inventors further discovered that the dendrimer biocide-silver nanocomposite structures are only stable in water. If the water was evaporated under vacuum, redissolution was impossible and a dark powder of Ag[0030] 2O was observed with powdered dendrimer biocide residue.
  • Because of these observations, the inventors believe that the novel dendrimer biocide-silver nanocomposite compounds contain both dendrimer and silver ions. While not wishing to be bound to a particular theory, the inventors believe that the silver ions may be absorbed on or complexed with the dendrimer. Depending on the composition of the solution, these nanocomposites can be stable for more than 3 months compared to several-hour stability of other dendrimer-nanocomposite preparations. [0031]
  • EXAMPLES
  • Preparation [0032]
  • Dendrimer biocide-silver nanocomposites were prepared by initially reacting silver nitrate (AgNO[0033] 3) with a D3ClNC8 dendrimer biocide to prepare a dendrimer biocide with nitrate counter-anion. The dendrimer biocide with nitrate counter-anion was prepared according to the method described above as follows:
  • 1. Adding excess AgNO[0034] 3 to a D3ClNC8 solution to convert the chloride anion of the dendrimer to nitrate ion;
  • 2. Precipitated AgCl was then centrifuged and excess NaCl solution was added to the supernatant liquid to remove any remaining AgNO[0035] 3 in the solution;
  • 3. After a dialysis to remove the remaining NaCl, a dendrimer biocide with NO[0036] 3—counter-anion is obtained.
  • Preparation of Ag-200 [0037]
  • The sample Ag-200 refers to the sample when a 200 percent stoichiometric amount of AgNO[0038] 3 was used in preparing the dendrimer biocide-silver nanocomposite. Approximately 0.1 gram of D3ClNC16 is dissolved in minimal amount of ethanol and dilute with water to obtain 10 mL solution. 10 mL of 0.1N AgNO3 is then added to change the counter anion of the dendrimer to nitrate. The solution is then centrifuged at 3000 g for 2 hours. The supematant is collected and 10 mL of 0.1N NaCl is added to remove the residual amount of AgNO3 in the solution. The excess NaCl was then removed with diafiltration of distilled water (1000 MWCO membrane). The final volume after diafiltration can be adjusted according to the desired concentration. Typically a 100 mL solution is achieved.
  • Preparation of Ag-500 [0039]
  • The sample Ag-500 refers to the sample when a 500 percent stoichiometric amount of AgNO[0040] 3 was used in preparing the dendrimer biocide-silver nanocomposite. Approximately 0.1 gram of D3ClNC16 is dissolved in minimal amount of ethanol and dilute with water to obtain 10 mL solution. 25 mL of 0.1N AgNO3 is then added to change the counter anion of the dendrimer to nitrate. The solution is then centrifuged at 3000 g for 2 hours. The supernatant is collected and 25 mL of 0.1N NaCl is added to remove the residual amount of AgNO3 in the solution. The excess NaCl was then removed with diafiltration of distilled water (1000 MWCO membrane).
  • The final volume after diafiltration can be adjusted according to the desired concentration. [0041]
  • Typically a 100 mL solution is achieved. [0042]
  • Measurement of Antimicrobial Properties [0043]
  • The antimicrobial properties of these composites were evaluated using a bioluminescence method. For these bioluminescence experiments, several strains of recombinant [0044] E. coli are used. The recombinant E. coli strains containing a fusion of Escherichia coli heat shock promoters and a lux gene of Vibrio fischeri were developed at DuPont. Relevant information regarding various strains is known to those skilled in the art.
  • [0045] E. coli stock solutions, kept at −80° C. freezer until required for use, were prepared in Lucia-Barton (LB) media supplemented with 20% glycerol. Glycerol was added to protect bacteria during freezing and thawing processes. During inoculation, a required amount of E. coli suspension (typically 10%) was added to fresh and sterile LB broth and incubated overnight at 37° C. These cells were also centrifuged and washed twice with phosphate buffered saline. Cell concentration was determined using a Petroff-Hausser counting chamber (Scientific Products, Edison, N.J.). Bacteria suspensions were then diluted to the test concentration. The recombinant E. coli strains were also stocked in a similar way to the wild-type E. coli. The medium used was Lucia-Barton (LB) supplemented with 25 mg/ml kanamycin monosulfate to maintain the plasmid. These plasmid-containing strains were grown to an early exponential phase at 30° C. The temperature used was lower than normal because enzymes responsible for generating light would be deactivated at 37° C. These cells were also centrifuged and washed twice with 0.1% peptone water before use.
  • There are a variety of methods that can be used to evaluate the antimicrobial properties of new materials. Method selection often depends on specific applications. Antimicrobial test results might be reported qualitatively, using terms as sensitive, intermediate, or resistant, or quantitatively in terms of concentration of an agent needed to inhibit or kill bacteria. Suspension tests are typically used to evaluate water-soluble antimicrobials, while surface antimicrobial tests are designed to characterize the antimicrobial properties of non-leaching biocidal materials. [0046]
  • During suspension tests, the effectiveness of biocides was quantified by mixing a suspension of viable bacteria and a certain concentration of test materials and monitoring the subsequent number of live cells at distinct time points. Bacteria were grown overnight and harvested as described. The plate-count method and bioluminescence test methods are two ways to quantify live cells. [0047]
  • In using the plate-count method, cells were re-suspended in a PBS buffer at a concentration between 1×108 and 1×109 cells/ml in sterile, 15-ml polypropylene centrifuge tubes (VWR Scientific Products, West Chester, Pa.). The viable cell concentration was determined by making a series of 10-fold dilutions of the cell suspension and spreading the bacteria on agar plates. The plates were then incubated over night at 30° C. for recombinant [0048] E. coli and 37° C. for wild-type E. coli. The visible colonies on the plates were then counted in 24-48 hours. Each colony represents one viable bacterium from the original suspension. The number of colonies, multiplied by the dilution, provides a measure of the viable cells in the original suspension.
  • In these studies, a dendrimer biocide was added to a cell suspension. The suspension was then agitated thoroughly with a vortexer (Scientific Products, McGraw Park, Ill.). Aliquots of the suspension were removed after 15, 30, and 60 minutes of biocide exposure. The aliquots were immediately used in a series of 10-fold dilutions with buffer containing 10% Tween 80 (Aldrich Chemical Company, Milwaukee, Wis.), which was utilized as a deactivating agent for the quaternized moieties. Without the denaturing agents, test samples would continue to exert its toxic influence, thereby increasing the apparent activity of the biocide. [0049]
  • For the bioluminescence experiments, several strains of recombinant [0050] E. coli were used. These recombinant E. coli strains containing a fusion of Escherichia coli heat shock promoters. Whenever bacteria receive stress from a toxic compound, the intensity of light emitted from the bacteria will change. From a “light-on” or “light-off” response one can obtain real-time cell viability data. Strain TV 1048, in which the lux operon is coupled to the promoter of lac operon, was used in this study. Bioluminescence is observed under normal growth conditions. Whenever the bacteria are in a biocidal environment, the light-off response quantitatively corresponds to the antibacterial effect.
  • During experiments, these plasmid-containing strains were grown to an early exponential phase at 30° C. in LB medium and then incubated with a known amount of the test sample. Bioluminescence was measured either in real time or at some time intervals using a luminometer (Model 20e, Turner Design, CA) and the data were recorded by a computer with data collection capacity. [0051]
  • The antibacterial property of the D3ClNC8 dendrimer biocide-silver nanocomposite against Gram-negative [0052] E. coli was determined by a bioluminescence method. Bioluminescence is observed under normal growth conditions for the recombinant E. coli strain TV 1048. Whenever the bacteria are in a biocidal environment, the light-off response corresponds to the toxic effect of the biocide. The result is expressed as the sample bioluminescence normalized to a control (without biocidal dendrimer of the present invention) versus time. The reduction of luminescence quantitatively shows the antibacterial activity of the sample.
  • At 4 ppm, the dendrimer biocide inhibited the growth of [0053] E. coli, but the bacteria could adjust to the environmental stress and survive. At higher concentrations (20 ppm), the bioluminescence decreased very rapidly and went down to undetectable levels in 15 min indicating a strong biocidal effect. In a control experiment, the bioluminescence of the bacteria did not change much (5%) if the same concentration of pure PPI generation 3 dendrimers was added.
  • The sample Ag-200 refers to the sample when a 200 percent stoichiometric amount of AgNO[0054] 3 was used in preparing the dendrimer biocide-silver nanocomposite. The Ag-200 formulation was observed to be much more potent than the dendrimer biocide alone. See FIG. 1. This figure shows that 2 ppm of D3ClNC8 reduces the bioluminescence to only 10 percent of the bioluminescence of the control. However, formulation Ag-500, containing only 0.8 ppm of D3ClNC8 and less than 0.8 ppm of Ag+ can reduce the bioluminescence to 0.1 percent of the control. The exact silver concentration was unknown since some AgCl precipitate consumed Ag+). The more potent formulation, Ag-200 with 0.8 ppm of D3ClNC8 and less than 0.3 ppm of Ag+ can reduce the bioluminescence to 0.001 percent of the control, which corresponded to a 5-order of magnitude reduction. The inventors further observed that the Ag-200 formulation is unexpectedly more potent than Ag-500 formulation.
  • The improvement of the potency may be explained by synergy between the dendrimer biocide and silver ions. Silver ions have been used as antimicrobials for 4000 years. The mode of action of silver ion is similar to Hg[0055] 2+. Both ions can complex with electron donor groups containing sulfur, oxygen or nitrogen. Silver parallels mercuric ions in relative affinities for various proteins, but is somewhat less tightly bound. Synergism is defined as the ability of two antimicrobials acting together to markedly increase the rate of the bacteriocidal action as compared to the rate of each antimicrobial alone. A typical example of synergy is between EDTA and QACs. EDTA is able to chelate the calcium and magnesium, thus destabilizes the phospholipid membrane and promotes the membrane-disrupting action of QACs.
  • While the invention has been particularly shown and described with reference to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made without departing from the spirit and scope of the invention as defined in the appended claims. [0056]

Claims (17)

What is claimed is:
1. A dendrimer biocide-silver nanocomposite composition comprising a quaternary ammonium dendrimer biocide and silver ions associated with said dendrimer biocide.
2. The dendrimer biocide-silver nanocomposite composition of claim 1 wherein greater than 1 percent stoichiometric amount of a silver compound is used to prepare the dendrimer biocide-silver nanocomposite.
3. The dendrimer biocide-silver nanocomposite composition of claim 1 wherein from about 200 to 500 percent stoichiometric amount of a silver compound is used to prepare the dendrimer biocide-silver nanocomposite.
4. The dendrimer biocide-silver nanocomposite composition of claim 1 wherein a 200 percent stoichiometric amount of a silver compound is used to prepare the dendrimer biocide-silver nanocomposite.
5. The dendrimer biocide-silver nanocomposite composition of claim 1 wherein a 500 percent stoichiometric amount of a silver compound is used to prepare the dendrimer biocide-silver nanocomposite.
6. The dendrimer biocide-silver nanocomposite composition of claim 1 wherein the dendrimer biocide is a D3ClNC8 dendrimer biocide.
7. A dendrimer biocide-silver nanocomposite prepared by a process comprising:
(a) adding excess AgNO3 to a dendrimer biocide solution to convert the chloride ion of the dendrimer biocide to a nitrate ion;
(b) removing any precipitated AgCl;
(c) removing any remaining AgNO3 in the solution by adding excess NaCl to the supernatant liquid; and
(d) diafiltering to remove remaining NaCl.
8. A method of controlling the growth of a microorganism comprising exposing said microorganism to a dendrimer biocide-silver nanocomposite composition comprising a quaternary ammonium dendrimer biocide and silver ions associated with said dendrimer biocide.
9. A method of controlling the growth of a microorganisms according to claim 8 wherein said microorganism is selected from the group consisting essentially of acidogenic gram-positive cocci, Gram-negative anaerobic oral bacteria, Group A streptococci, enteric bacteria, Gram-negative rods, and Gram-positive cocci.
10. A method of controlling the growth of a microorganisms according to claim 8 wherein said microorganism is selected from the group consisting essentially of streptococcus, staphylococci, haemophilus influenzae, escherichia coli, P. aeruginosa, burkholderia cepacia, Pseudomonas pseudomallei, C. albicansm, staphylococcus epidermidis, and S. aureus.
11. A method of controlling the growth of a microorganism according to claim 8 wherein said microorganism is a spore.
12. A method of controlling the growth of a microorganism according to claim 11 wherein said spore corresponds to B. anthracis or anthrax.
13. A method of controlling the growth of a microorganism according to claim 8 wherein said dendrimer biocide-silver nanocomposite is immobilized on a surface.
14. A method of controlling the growth of a microorganism according to claim 13 wherein said surface is comprised of a polymer, or glass, or metal.
15. A method of controlling the growth of a microorganism according to claim 14 wherein said surface polymer is selected from the group consisting of polyurethane, polystyrene, polyethylene, and polypropylene.
16. A method of controlling the growth of a microorganism according to claim 8 wherein said dendrimer biocide-silver nanocomposite is applied as a spray.
17. A method of controlling the growth of a microorganism according to claim 8 wherein said dendrimer biocide-silver nanocomposite is incorporated into a coating.
US10/309,628 2000-06-09 2002-12-04 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials Abandoned US20030082133A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/309,628 US20030082133A1 (en) 2000-06-09 2002-12-04 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21088800P 2000-06-09 2000-06-09
US09/877,931 US6579906B2 (en) 2000-06-09 2001-06-08 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials
US10/309,628 US20030082133A1 (en) 2000-06-09 2002-12-04 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/877,931 Continuation US6579906B2 (en) 2000-06-09 2001-06-08 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Publications (1)

Publication Number Publication Date
US20030082133A1 true US20030082133A1 (en) 2003-05-01

Family

ID=26905602

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/877,931 Expired - Lifetime US6579906B2 (en) 2000-06-09 2001-06-08 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials
US10/309,628 Abandoned US20030082133A1 (en) 2000-06-09 2002-12-04 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/877,931 Expired - Lifetime US6579906B2 (en) 2000-06-09 2001-06-08 Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Country Status (1)

Country Link
US (2) US6579906B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040031749A1 (en) * 2002-01-31 2004-02-19 Koslow Evan E. Structures that inhibit microbial growth
US6835311B2 (en) 2002-01-31 2004-12-28 Koslow Technologies Corporation Microporous filter media, filtration systems containing same, and methods of making and using
US20060188537A1 (en) * 2005-02-22 2006-08-24 Lamba-Kohli Nina M Generation of antimicrobial surfaces using dendrimer biocides
US20060269441A1 (en) * 2005-05-25 2006-11-30 Ochomogo Maria G Nanosilica-based food contact sanitizer
EP2140958A2 (en) 2008-07-04 2010-01-06 Thüringisches Institut Für Textil- Und Kunststoff- Forschung E.V. Method for manufacturing metallic nanoparticle dispersions and products made from them
US20100136072A1 (en) * 2006-11-08 2010-06-03 Massachusetts Institute Of Technology Polymeric Coatings that Inactivate Viruses and Bacteria
WO2012150506A2 (en) * 2011-05-02 2012-11-08 Indian Institute Of Technology Single container gravity-fed storage water purifier
RU2548093C2 (en) * 2012-06-25 2015-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный университет" Catalytic process of formaldehyde removal from aqueous solutions
US10035131B2 (en) 2011-11-24 2018-07-31 Indian Institute Of Technology Multilayer organic-templated-boehmite-nanoarchitecture for water purification
US10041925B2 (en) 2012-04-17 2018-08-07 Indian Institute Of Technology Detection of quantity of water flow using quantum clusters

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072937A1 (en) * 2001-02-10 2004-04-15 Tomalia Donald A. Nanocomposites of dendritic polymers
US6579906B2 (en) * 2000-06-09 2003-06-17 University Of Delaware Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials
US7655112B2 (en) * 2002-01-31 2010-02-02 Kx Technologies, Llc Integrated paper comprising fibrillated fibers and active particles immobilized therein
TW200306225A (en) * 2002-02-22 2003-11-16 Rohm & Haas Chemical and biological decontamination material and system
US20030185889A1 (en) * 2002-03-27 2003-10-02 Jixiong Yan Colloidal nanosilver solution and method for making the same
WO2004019993A1 (en) * 2002-08-30 2004-03-11 Ramot At Tel Aviv University Ltd. Self-immolative dendrimers releasing many active moieties upon a single activating event
US7276166B2 (en) * 2002-11-01 2007-10-02 Kx Industries, Lp Fiber-fiber composites
US7048864B2 (en) * 2003-03-24 2006-05-23 King Technology Inc. Dendrimer fluid purification system and method
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US7560520B1 (en) 2004-11-08 2009-07-14 The United States Of America As Represented By The Secretary Of The Army Interface-directed branched polymer transports and methods for producing same
WO2006099359A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
EP1898900B1 (en) 2005-03-10 2011-06-08 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
US8119548B2 (en) * 2005-05-18 2012-02-21 Building Materials Investment Corporation Nanosilver as a biocide in building materials
US20060269480A1 (en) * 2005-05-31 2006-11-30 Ramot At Tel Aviv University Ltd. Multi-triggered self-immolative dendritic compounds
DE102005044361A1 (en) * 2005-09-09 2007-03-15 Aesculap Ag & Co. Kg Antimicrobial medical device product, process for its preparation and use
US9603941B2 (en) * 2006-01-24 2017-03-28 Minghui Chai Method of preparing dendritic drugs
DE102006046073A1 (en) * 2006-09-27 2008-04-03 Henkel Kgaa Hyperbranched polymers for hygienic equipment
CA2667307C (en) 2006-10-27 2015-12-01 3M Innovative Properties Company Antimicrobial compositions comprising a c2-c5 lower alcohol, a cationic antimicrobial agent, and a fatty component containing free hydroxyl groups
US8425880B1 (en) * 2007-05-02 2013-04-23 Nucryst Pharmaceuticals Corp. Metal-containing materials for treatment of bacterial conditions
US8268359B2 (en) * 2009-08-26 2012-09-18 Indian Institute Of Technology Madras Organic polymer-inorganic fine particle antimicrobial composites and uses thereof
AT509235B1 (en) * 2010-01-13 2012-07-15 Bader Daniel SILVER-CONTAINING BIOZIDE EFFECTIVE AQUEOUS COMPOSITION
EP2741912A4 (en) 2011-08-11 2015-04-08 3M Innovative Properties Co Nonwoven webs and multi-component fibers comprising a polydiorganosiloxane polyamide and methods of melt blowing
WO2015050749A1 (en) 2013-10-04 2015-04-09 3M Innovative Properties Company Multi-component fibers, nonwoven webs, and articles comprising a polydiorganosiloxane polyamide
GB201405660D0 (en) 2014-03-28 2014-05-14 Gama Healthcare Ltd A liquid disinfecting composition
EP2982247A1 (en) 2014-08-07 2016-02-10 Omya International AG Antiseptic product, process for preparing same and its use
US11344707B2 (en) * 2016-11-28 2022-05-31 Therma Bright Inc. Devices for applying a topical treatment
CN108129066B (en) * 2017-12-30 2020-12-01 义乌市君胜科技有限公司 Preparation method of silver-loaded palygorskite heat-resistant liquid wallpaper
US10806140B2 (en) 2018-04-12 2020-10-20 Physical Sciences, Inc. Antimicrobial compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938934A (en) * 1998-01-13 1999-08-17 Dow Corning Corporation Dendrimer-based nanoscopic sponges and metal composites
US6224898B1 (en) * 2000-03-23 2001-05-01 The United States Of America As Represented By The Secretary Of The Army Antimicrobial dendrimer nanocomposites and a method of treating wounds
US6579906B2 (en) * 2000-06-09 2003-06-17 University Of Delaware Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006691A2 (en) 1996-08-14 1998-02-19 Warner-Lambert Company Low molecular weight dendritic compounds as pharmaceutical agents
WO1998026662A1 (en) 1996-12-19 1998-06-25 The Penn State Research Foundation Compounds and methods for treating and preventing bacterial and viral disease
US5962423A (en) 1998-08-07 1999-10-05 The Governors Of The University Of Alberta Treatment of bacterial dysentery
US6440405B1 (en) * 1999-06-07 2002-08-27 University Of Delaware Quaternary ammonium functionalized dendrimers and methods of use therefor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5938934A (en) * 1998-01-13 1999-08-17 Dow Corning Corporation Dendrimer-based nanoscopic sponges and metal composites
US6224898B1 (en) * 2000-03-23 2001-05-01 The United States Of America As Represented By The Secretary Of The Army Antimicrobial dendrimer nanocomposites and a method of treating wounds
US6579906B2 (en) * 2000-06-09 2003-06-17 University Of Delaware Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8056733B2 (en) 2002-01-31 2011-11-15 Kx Technologies Llc Structures that inhibit microbial growth
US7287650B2 (en) * 2002-01-31 2007-10-30 Kx Technologies Llc Structures that inhibit microbial growth
US20040031749A1 (en) * 2002-01-31 2004-02-19 Koslow Evan E. Structures that inhibit microbial growth
US6835311B2 (en) 2002-01-31 2004-12-28 Koslow Technologies Corporation Microporous filter media, filtration systems containing same, and methods of making and using
US20060188537A1 (en) * 2005-02-22 2006-08-24 Lamba-Kohli Nina M Generation of antimicrobial surfaces using dendrimer biocides
US8790672B2 (en) 2005-02-22 2014-07-29 Nina M. Lamba-Kohli Generation of antimicrobial surfaces using dendrimer biocides
US20060269441A1 (en) * 2005-05-25 2006-11-30 Ochomogo Maria G Nanosilica-based food contact sanitizer
US20100136072A1 (en) * 2006-11-08 2010-06-03 Massachusetts Institute Of Technology Polymeric Coatings that Inactivate Viruses and Bacteria
DE102008031310A1 (en) 2008-07-04 2010-01-07 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. Process for the preparation of metal nanoparticle dispersions and products thereof
EP2140958A2 (en) 2008-07-04 2010-01-06 Thüringisches Institut Für Textil- Und Kunststoff- Forschung E.V. Method for manufacturing metallic nanoparticle dispersions and products made from them
WO2012150506A2 (en) * 2011-05-02 2012-11-08 Indian Institute Of Technology Single container gravity-fed storage water purifier
WO2012150506A3 (en) * 2011-05-02 2012-12-27 Indian Institute Of Technology Single container gravity-fed storage water purifier
US20140216993A1 (en) * 2011-05-02 2014-08-07 Indian Institute Of Technology Single container gravity-fed storage water purifier
US10035131B2 (en) 2011-11-24 2018-07-31 Indian Institute Of Technology Multilayer organic-templated-boehmite-nanoarchitecture for water purification
US10041925B2 (en) 2012-04-17 2018-08-07 Indian Institute Of Technology Detection of quantity of water flow using quantum clusters
RU2548093C2 (en) * 2012-06-25 2015-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный университет" Catalytic process of formaldehyde removal from aqueous solutions

Also Published As

Publication number Publication date
US6579906B2 (en) 2003-06-17
US20020022012A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
US6579906B2 (en) Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials
US6440405B1 (en) Quaternary ammonium functionalized dendrimers and methods of use therefor
Chen et al. Recent advances in antimicrobial dendrimers
Kanazawa et al. Polymeric phosphonium salts as a novel class of cationic biocides. IV. Synthesis and antibacterial activity of polymers with phosphonium salts in the main chain
Yuan et al. Water-dispersible and biodegradable polymer micelles with good antibacterial efficacy
Wiarachai et al. Surface-quaternized chitosan particles as an alternative and effective organic antibacterial material
MXPA05008579A (en) Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems.
Anaya‐Plaza et al. Photoantimicrobial biohybrids by supramolecular immobilization of cationic phthalocyanines onto cellulose nanocrystals
US7384626B2 (en) Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
Hussein et al. Exploring the physicochemical and antimicrobial properties of gold-chitosan hybrid nanoparticles composed of varying chitosan amounts
Chen et al. Incorporation of dimethyldodecylammonium chloride functionalities onto poly (propylene imine) dendrimers significantly enhances their antibacterial properties
Kim et al. Preparation of alginate–quaternary ammonium complex beads and evaluation of their antimicrobial activity
US20100015083A1 (en) Method of producing pvp/fullerene complex and aqueous solution thereof
Sanchez-Milla et al. Functionalization of silica with amine and ammonium alkyl chains, dendrons and dendrimers: Synthesis and antibacterial properties
Guo et al. Acidity-activated charge-convertible silver nanocomposites for enhanced bacteria-specific aggregation and antibacterial activity
Pranantyo et al. Nontoxic antimicrobial cationic peptide nanoconstructs with bacteria-displaceable polymeric counteranions
US8097343B2 (en) Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
US9403944B2 (en) Antipathogenic guanidinium copolymer
Su et al. Cyclotriphosphazene-based derivatives for antibacterial applications: an update on recent advances
US8329155B2 (en) Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof
CN110776551A (en) Polymerizable rosin quaternary ammonium salt bactericide, preparation method thereof and polymerized rosin quaternary ammonium salt bactericide prepared from polymerizable rosin quaternary ammonium salt bactericide
WO2021245707A1 (en) Synthesis of aminoacid conjugate of tris(hydroxymethyl)phosphine and nanoparticle composition thereof
Subashini et al. Biological applications of green synthesized zinc oxide and nickel oxide nanoparticles mediated poly (glutaric acid-co-ethylene glycol-co-acrylic acid) polymer nanocomposites
EP3136864A1 (en) Compositions, methods of making a composition, and methods of use
CN110495473A (en) A kind of molybdenum disulfide/bis- phenylalanines antibacterial agent and preparation method and application

Legal Events

Date Code Title Description
AS Assignment

Owner name: UD TECHNOLOGY CORPORATION, DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THE UNIVERSITY OF DELAWARE OFFICE OF THE VICE PROVOST FOR RESEARCH;REEL/FRAME:014420/0330

Effective date: 20030813

AS Assignment

Owner name: UNIVERSITY OF DELAWARE, DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:UD TECHNOLOGY CORPORATION;REEL/FRAME:021195/0485

Effective date: 20080620

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION